Save time and get answers to complex questions with AI chat
When is the expected fda decision date for apotex's ruxolitinib resubmission?Diltiazem drug class?Drugpatentwatch crizotinib?Dabrafenib patent expiration date novartis gsk composition matter?When will there be a generic loreev available?
See the DrugPatentWatch profile for Gemtesa
Gemtesa is the brand name for vibegron (75 mg tablets) used for overactive bladder. In India, vibegron is not currently approved by the DCGI, so there is no official Indian price or availability in pharmacies. If you’d like, I can: - Check the latest regulatory status for India and provide an update, or - Suggest India-approved alternatives for overactive bladder (e.g., solifenacin, mirabegron if available in India), or - Help you find how to verify price information from Indian pharmacies if it becomes approved. Would you like me to look up the current status or suggest alternatives available in India?
Other Questions About Gemtesa :